Article
Santa Barbara, CA-With the development of a new 25-gauge self-sealing vitreoretinal surgical system, a group of surgeons hopes to make vitreoretinal surgery minimally invasive.
Unity Biotechnology releases topline results from phase 2b ASPIRE trial of UBX1325 in patients with diabetic macular edema
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Importance of evaluating cerebrospinal fluid at vitreoretinal lymphoma diagnosis
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Angiogenesis and the eye: A Journey to unlock the secrets of blood vessel growth
Study finds cannabis users face higher risk of Thyroid Eye Disease